Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase I Safety Study of DMXAA in Refractory Tumors (DART)
This study has been completed.
Study NCT00856336   Information provided by Antisoma Research

First Received on March 4, 2009.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Refractory Tumors
Interventions listed in this trial
DMXAA
Additional drug interventions recognized in this trial
5,6-dimethylxanthenoneacetic acid
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Antisoma Research


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services